The test was developed by Oxford Biodynamics in collaboration with UEA, Imperial College London and Imperial College NHS Trust. Prof Dmitry Pshezhetskiy, from UEA's Norwich Medical School, said: "Prostate cancer is the most common cancer in men and kills one man every 45 minutes in the UK. ...
PSACheck enables men to have the test performed and provides all the necessary support and guidance should the test flag anything of concern. An early PSA test as a ‘marker in the sand’ is very useful and can be used for future comparison and improves hugely the utility of this simple a...
Using expected remaining lifetimes for the UK male population in 2001–2003, and estimates of lead time from the literature, age-specific probabilities of overdiagnosis were calculated. Applying these probabilities to the number of cases with prediagnosis PSA test, the number of overdiagnosed cases a...
Prosdex is a web-based decision aid to help men consider whether or not to have a Prostate Specific Antigen (PSA) test, potentially for prostate cancer [1]. It was developed in the context of the UK Prostate Cancer Risk Management Programme (PCRMP), a strategy, promoted by the UK Nation...
Targeting tests for prostate cancer at the men most likely to develop the disease could halve the number needed to be screened, reduce overdiagnosis, and potentially save the NHS millions of pounds, suggests research. With funding from Cancer Research UK, researchers from London and Cambridge ...
University College London Hospitals NHS Foundation Trust, London, UK Anita Mitra & Paul Cathcart Queen Mary University of London, London, UK Judith Offman & Sue Moss Guy’s Hospital, London, UK Judith Offman CHS National Cancer Control Center, Carmel Medical Center, Haifa, UK Gad Rennert Wess...
(Cancer Research UK), Harry De Koning, PhD (Erasmus Medical Centre), Jenny Donovan, PhD (University of Bristol), Ruth Etzioni, PhD (Fred Hutchinson Cancer Research Center), Simon Evans, MD (Royal United Hospital Bath NHS Foundation Trust), Roman Gulati, MS (Fred Hutchinson Cancer Research ...
The UK government's argument about the cost to the NHS of setting up such a screening programme also seems difficult to understand. A PSA test costs between pounds 5 and pounds 10, although there are further financial implications because a number of men will need follow-up investigations, ...
Written byJason Armstrong Prostate cancer is the most common form of cancer in men. In the UK, 1 in every 8 men will be diagnosed with the condition within their lifetime, resulting in around 12’000 deaths per year1. Prostate-specific antigen is a major protease found in semen which fun...
University NHS Trust, Cambridge, UK and 3Department of Postgraduate Medicine, Cranfield University, Cranfield, UK. Correspondence: Professor R Thomas, Bedford and Addenbrooke's Cambridge University NHS Hospitals, c/o The Research Unit, Primrose Oncology, Bedford Hospital, Bedford MK42 9DJ, UK. E...